Skip to main content
NIH funding notice RFA-TR-21-015

Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed)

Closed on June 28, 2021.

Posted
April 2, 2021
Close date
June 28, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$433,139
$866,278 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
  2. UNIVERSITY OF TEXAS MED BR GALVESTON1

Most frequent study sections

  1. Special Emphasis Panel (ZTR1 DPI-3 (01))2
2 awards under RFA-TR-21-015 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2022Re-engineering a human 3D liver tissue model for non-alcoholic fatty liver disease for drug screening1UH2TR004124-01Miedel, Mark T.UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PAFirst-year cost $436,677Study section ZTR1
FY20223-D biofabricated feto-maternal interface tissue model to determine drug efficacy during pregnancy to reduce the risk of preterm birth1UH2TR004117-01Han, ArumMenon, RamkumarUNIVERSITY OF TEXAS MED BR GALVESTON, TXFirst-year cost $429,601Study section ZTR1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-TR-21-015: Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed) | ScienceDex | ConductScience